THE SYSTOLIC AND DIASTOLIC BLOOD PRESSURE VALUES IN FEMALE RABBITS WITH METABOLIC SYNDROME

Mavlonov Anvar

Authors

Mavlonov Anvar Bukhara State Medical Institute, Bukhara, Bukhara Region, Uzbekistan.

Keywords:

Systolic blood pressure, diastolic blood pressure, metabolic syndrome, female rabbits, hypertension, cardiovascular risk.

Abstract

Objective: This study investigates the systolic and diastolic blood pressure (BP) values in female rabbits with a metabolic syndrome (MS) model. Metabolic syndrome, characterized by a cluster of conditions including hypertension, is a significant risk factor for cardiovascular diseases. Understanding BP changes in an MS model can provide insights into the pathophysiology of hypertension associated with metabolic syndrome. Methods: Female rabbits were induced with metabolic syndrome through a high-fat, high-sucrose diet over a period of 12 weeks. A control group was maintained on a standard diet. Systolic and diastolic BP measurements were taken at baseline and at regular intervals using a non-invasive tail-cuff method. BP values were compared between the control and MS groups, and statistical analysis was performed to assess the significance of observed differences. Results: The MS group exhibited a significant increase in both systolic and diastolic BP values compared to the control group. By the end of the study period, the mean systolic BP in the MS group was notably higher, indicative of sustained hypertension. Similarly, the diastolic BP values were elevated, reflecting increased vascular resistance and potential endothelial dysfunction. These changes were consistent with the development of other metabolic syndrome features such as insulin resistance, hyperlipidemia, and obesity. Conclusion: Female rabbits with an induced metabolic syndrome model showed significant elevations in systolic and diastolic blood pressure, highlighting the hypertensive component of metabolic syndrome. These findings underscore the importance of managing BP in individuals with metabolic syndrome to reduce the risk of cardiovascular complications. Further research is warranted to explore the underlying mechanisms and potential therapeutic interventions to mitigate hypertension in metabolic syndrome.

References

Anvar, M., Saidamir, S., Jakhongir, M., Rano, B. (2024). Features of bone destruction in rabbits with experimental metabolic syndrome. The Scientific Temper, 15(1):1941-1948. Doi: 10.58414/SCIENTIFICTEMPER.2024.15.1.48.

Yunuskhodjaev Akhmadkhodja, Mavlonov Anvar, Saidov Saidamir, Boboeva Rano. Estimation of Bone Tissue Changes in Experimental Animals with Metabolic Syndrome under Using MSCT. American Journal of Medicine and Medical Sciences. 2024; 14(6): 1475-1482. doi: 10.5923/j.ajmms.20241406.01

Alessi M. C., Juhan–Vague I. PAI–1 and the metabolic syndrome: the links, causes and consequences. Arterioscler Thromb Vasc Biol 2006; 26 (10): 2200–7.

I. Watt, M. Doherty Plain Radiographic Features of Osteoarthritis KD Brandt, M. Doherty, LS Lohmander (Eds.), Osteoarthritis, Oxford University Press, New York (2003), LC Rovati Radiographic Evaluation. 7 (1999), 427-429.

M.A. D'Anjou, M. Moreau, E. Troncy, J. Martel. Pelletier, F. Abram, JP Raynauld et al. Osteophytosis, subchondral bone sclerosis, joint effusion and soft tissue in canine experimental stifling osteoarthritis tissue thickening: a comparison between 1.5 T magnetic resonance imaging and computer radiography. Vet Surg, 37 (2008), 116-177).

Van Ginneken B, ter Haar Romeny BM, Viergever MA. Computer-aided diagnosis in chest radiography: a survey. IEEE Trans Med Imaging (2001) 20:1228–41. doi: 10.1109/42.974918.

Alberti K.G., Zimmet P., Shaw J., IDF Epidemiology Task Force Consensus Group. The metabolic syndrome — a new worldwide definition // Lancet. — 2005. — Vol. 366, № 9491. — P. 1059–1062.

Kovaleva M.A., Makarova M.N., Selezneva A.I., Makarov V.G. Primenenie zhivotnyh so spontannoj gipertenziej dlja modelirovanija metabolicheskogo sindroma. Obzory po klinicheskoj farmakologii i lekarstvennoj terapii, 2012; 4: 91–94.

Neuhofer A., Wernly B., Leitner L., Sarabi A., Sommer N.G., Staffler G., Zeyda M., Stulnig T.M. An accelerated mouse model for atherosclerosis and adipose tissue inflammation. Cardiovasc Diabetol. 2014 Jan 17;13:23. DOI: 10.1186/1475-2840-13-23.

Aydin S., Aksoy A., Aydin S., Kalayci M., Yilmaz M., Kuloglu T., Citil C., Catak Z. Today’s and yesterday’s of pathophysiology: Biochemistry of metabolic syndrome and animal models / Suleyman Aydin [et al.]. Nutrition. 2014. Jan; 30 (1): 1–9.

Wong SK, Chin KY, Suhaimi FH, Fairus A, Ima-Nirwana S. Animal models of metabolic syndrome: a review. Nutrition & metabolism. 2016; 13:65.

Nomura A., Won H.H., Khera A.V. et al. (2017) Protein-Truncating Variants at the Cholesteryl Ester Transfer Protein Gene and Risk for Coronary Heart Disease. Circ. Res., 121(1): 81–88.